Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02793492 · ClinicalTrials.gov registry record · NA
Misago® RX Self-expanding Peripheral Stent for Common And/or External Iliac Artery
A NA study of Iliac Artery Stenosis, sponsored by Terumo Medical Corporation.
- Active
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 9
- Study locations
NCT02793492: Active NA study of Iliac Artery Stenosis, sponsored by Terumo Medical Corporation.
NCT02793492 is a NA study of Iliac Artery Stenosis that is active but no longer recruiting, run by Terumo Medical Corporation. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02793492, a NA study of Iliac Artery Stenosis, is active but no longer recruiting, sponsored by Terumo Medical Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.
Conditions Studied
Interventions
- DEVICE Misago® RX Self-expanding Peripheral Stent
Study Locations (9)
Florida
- University of Florida Health - Gainesville
- First Coast Cardiovascular Institute - Jacksonville
Texas
- Texas Tech University Health Sciences Center - Lubbock
- The Heart Hospital Baylor Plano - Plano
Colorado
- ClinRe Inc. Advanced Heart and Vein Center - Thornton
Louisiana
- Cardiovascular Institute of the South - Lafayette
New Jersey
- Holy Name Medical Center - Teaneck
North Carolina
- Novant Health - Matthews
Ohio
- The Christ Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-08-30 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02793492
The ClinicalTrials.gov registry entry for NCT02793492 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The listed sponsor is Terumo Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Iliac Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Misago® RX Self-expanding Peripheral Stent is the first listed.
NCT02793492 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Florida, Texas, Colorado.
Frequently Asked Questions
What is clinical trial NCT02793492 about?
NCT02793492 is a clinical study titled "Misago® RX Self-expanding Peripheral Stent for Common And/or External Iliac Artery". This is a multi-center, single arm, non-randomized, prospective clinical study using the Misago® RX Self-expanding Peripheral Stent for treatment of de novo, restenotic, and/or occlusive lesion(s) of the common and/or external iliac artery.
What is the current status of trial NCT02793492?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-08-30. Estimated completion is 2026-09.
What conditions does trial NCT02793492 study?
This clinical trial studies the following conditions: Iliac Artery Stenosis.
What interventions are being tested in trial NCT02793492?
The interventions under investigation include: Misago® RX Self-expanding Peripheral Stent (DEVICE).
Who is sponsoring clinical trial NCT02793492?
This trial is sponsored by Terumo Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02793492 being conducted?
This trial has 9 study locations across Colorado, Florida, Louisiana, New Jersey, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.